α-Phenyl-n-tert-butylnitrone attenuates hyperoxia-induced lung injury by down-modulating inflammation in neonatal rats

Experimental Lung Research

Volumn 35, Issue 3, 2009, Pages 234-249

  Chang, Yun Sil ^a,b   Kim, Yu Jin ^a   Yoo, Hye Soo ^a   Sung, Dong Kyung ^b   Kim, Soo Yoon ^b   Kang, Saem ^b   Park, Won Soon ^a,b  

^a Sungkyunkwan University   (South Korea)

^b Samsung Medical Center   (South Korea)

Author keywords

phenyl N tert butylnitrone; Animals; Bronchopulmonary dysplasia; Inflammation; Newborns

Indexed keywords

INTERLEUKIN 6; MESSENGER RNA; N TERT BUTYL ALPHA PHENYLNITRONE; OXYGEN; PROTEIN P67; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; AMINE OXIDE; CYTOKINE; NEUTROPHIL CYTOSOL FACTOR 67K; PHENYL-N-TERT-BUTYLNITRONE; PHOSPHOPROTEIN; SCAVENGER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; FEMALE; HYPEROXIA; INFLAMMATION; LUNG ALVEOLUS; LUNG INJURY; NEWBORN; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT; UPREGULATION; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; PATHOLOGY;

ANIMALS; ANIMALS, NEWBORN; CYCLIC N-OXIDES; CYTOKINES; FREE RADICAL SCAVENGERS; GENE EXPRESSION REGULATION; HYPEROXIA; INFLAMMATION; LUNG INJURY; PHOSPHOPROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 67149096117     PISSN: 01902148     EISSN: 15210499     Source Type: Journal    
DOI: 10.1080/01902140802573007     Document Type: Article

References (50)

1. Bland RD: Neonatal chronic lung disease in the post-surfactant era. Biol Neonate. 2005;88:181-191.
2. Bhandari A, Panitch HB: Pulmonary outcomes in bronchopulmonary dysplasia. Semin Perinatol. 2006;30:219-226.
3. Coalson JJ: Pathology of new bronchopulmonary dysplasia. Semin Neonatol. 2003;8:73-81.
4. Kramer BW: Antenatal inflammation and lung injury: prenatal origin of neonatal disease. J Perinatol. 2008;28(Suppl 1):S21-S27.
5. Chess PR, D'Angio CT, Pryhuber GS, Maniscalco WM: Pathogenesis of bronchopulmonary dysplasia. Semin Perinatol. 2006;30:171-178.
6. Walsh MC, Szefler S, Davis J, Allen M, Van Marter L, Abman S, Blackmon L, Jobe A: Summary proceedings from the bronchopulmonary dysplasia group. Pediatrics. 2006;117:S52-S56.
7. Defraigne JO, Detry O, Pincemail J, Franssen C, Meurisse M, Lamy M, Limet R: Direct evidence of free radical production after ischaemia and reperfusion and protective effect of desferrioxamine: ESR and vitamin E studies. Eur J Vasc Surg. 1994;8:537-543.
8. Carney JM, Floyd RA: Protection against oxidative damage to CNS by alpha-phenyl-tert-butyl nitrone (PBN) and other spin-trapping agents: a novel series of nonlipid free radical scavengers. J Mol Neurosci. 1991;3:47-57.
9. Cao X, Phillis JW: alpha-Phenyl-tert-butyl-nitrone reduces cortical infarct and edema in rats subjected to focal ischemia. Brain Res. 1994;644:267-272.
10. Atamna H, Paler-Martinez A, Ames BN: N -t-butyl hydroxylamine, a hydrolysis product of alpha-phenyl-N-t-butyl nitrone, is more potent in delaying senescence in human lung fibroblasts. J Biol Chem. 2000;275:6741-6748.
11. Sata T, Kubota E, Misra HP, Mojarad M, Pakbaz H, Said SI: Paraquat-induced lung injury: prevention by N-tert-butyl-alpha- phenylnitrone, a free-radical spin-trapping agent. Am J Physiol. 1992;262:L147-L152.
12. Pogrebniak HW, Merino MJ, Hahn SM, Mitchell JB, Pass HI: Spin trap salvage from endotoxemia: the role of cytokine down-regulation. Surgery. 1992;112:130-139; discussion 138-139.
13. Stewart CA, Hyam K, Wallis G, Sang H, Robinson KA, Floyd RA, Kotake Y, Hensley K: Phenyl-N-tert-butylnitrone demonstrates broad-spectrum inhibition of apoptosis-associated gene expression in endotoxin-treated rats. Arch Biochem Biophys. 1999;365:71-74.
14. Naito Y, Takagi T, Ishikawa T, Handa O, Matsumoto N, Yagi N, Matsuyama K, Yoshida N, Yoshikawa T, Kotake Y: alpha-Phenyl-N-tert-butylnitrone provides protection from dextran sulfate sodium-induced colitis in mice. Antioxid Redox Signal. 2002;4:195-206.
15. Cooney TP, Thurlbeck WM: The radial alveolar count method of Emery and Mithal: a reappraisal 1 - postnatal lung growth. Thorax. 1982;37:572-579.
16. Cooney TP, Thurlbeck WM: The radial alveolar count method of Emery and Mithal: a reappraisal 2 - intrauterine and early postnatal lung growth. Thorax. 1982;37:580-583.
17. Babior BM: NADPH oxidase: an update. Blood. 1999;93:1464-1476.
18. Cross AR, Segal AW: The NADPH oxidase of professional phagocytes - prototype of the NOX electron transport chain systems. Biochim Biophys Acta. 2004;1657:1-22.
19. Robinson JM, Badwey JA: The NADPH oxidase complex of phagocytic leukocytes: a biochemical and cytochemical view. Histochem Cell Biol. 1995;103:163-180.
20. Hohler B, Holzapfel B, Kummer W: NADPH oxidase subunits and superoxide production in porcine pulmonary artery endothelial cells. Histochem Cell Biol. 2000;114:29-37.
21. Li JM, Shah AM: Intracellular localization and preassembly of the NADPH oxidase complex in cultured endothelial cells. J Biol Chem. 2002;277:19952- 19960.
22. Yam J, Frank L, Roberts RJ: Oxygen toxicity: comparison of lung biochemical responses in neonatal and adult rats. Pediatr Res. 1978;12:115-119.
23. Kunig AM, Balasubramaniam V, Markham NE, Morgan D, Montgomery G, Grover TR, Abman SH: Recombinant human VEGF treatment enhances alveolarization after hyperoxic lung injury in neonatal rats. Am J Physiol Lung Cell Mol Physiol. 2005;289:L529-L535.
24. Warner BB, Stuart LA, Papes RA, Wispe JR: Functional and pathological effects of prolonged hyperoxia in neonatal mice. Am J Physiol. 1998;275:L110-L117.
25. Jobe AJ: The new BPD: an arrest of lung development. Pediatr Res. 1999;46:641-643.
26. Bucher JR, Roberts RJ: The development of the newborn rat lung in hyperoxia: a dose-response study of lung growth, maturation, and changes in antioxidant enzyme activities. Pediatr Res. 1981;15:999-1008.
27. McGrath-Morrow SA, Stahl J: Apoptosis in neonatal murine lung exposed to hyperoxia. Am J Respir Cell Mol Biol. 2001;25:150-155.
28. Saugstad OD: Bronchopulmonary dysplasia-oxidative stress and antioxidants. Semin Neonatol. 2003;8:39-49.
29. Li J, Gao X, Qian M, Eaton JW: Mitochondrial metabolism underlies hyperoxic cell damage. Free Radic Biol Med. 2004;36:1460-1470.
30. Parinandi NL, Kleinberg MA, Usatyuk PV, Cummings RJ, Pennathur A, Cardounel AJ, Zweier JL, Garcia JG, Natarajan V: Hyperoxia-induced NAD(P)H oxidase activation and regulation by MAP kinases in human lung endothelial cells. Am J Physiol Lung Cell Mol Physiol. 2003;284:L26-L38.
31. Bastian NR, Hibbs JB, Jr.: Assembly and regulation of NADPH oxidase and nitric oxide synthase. Curr Opin Immunol. 1994;6:131-139.
32. Moores HK, Beehler CJ, Hanley ME, Shanley PF, Stevens EE, Repine JE, Terada LS: Xanthine oxidase promotes neutrophil sequestration but not injury in hyperoxic lungs. J Appl Physiol. 1994;76:941-945.
33. Kinnula VL, Chang LY, Ho YS, Crapo JD: Hydrogen peroxide release from alveolar macrophages and alveolar type II cells during adaptation to hyperoxia in vivo. Exp Lung Res. 1992;18:655-673.
34. Delacourt C, d'Ortho MP, Macquin-Mavier I, Pezet S, Housset B, Lafuma C, Harf A: Oxidant-antioxidant balance in alveolar macrophages from newborn rats. Eur Respir J. 1996;9:2517-2524.
35. Lindsay L, Oliver SJ, Freeman SL, Josien R, Krauss A, Kaplan G: Modulation of hyperoxia-induced TNF-alpha expression in the newborn rat lung by thalidomide and dexamethasone. Inflammation. 2000;24:347-356.
36. Kotecha S, Wangoo A, Silverman M, Shaw RJ: Increase in the concentration of transforming growth factor beta-1 in bronchoalveolar lavage fluid before development of chronic lung disease of prematurity. J Pediatr. 1996;128:464-469.
37. Lecart C, Cayabyab R, Buckley S, Morrison J, Kwong KY, Warburton D, Ramanathan R, Jones CA, Minoo P: Bioactive transforming growth factor-beta in the lungs of extremely low birthweight neonates predicts the need for home oxygen supplementation. Biol Neonate. 2000;77:217-223.
38. Kwong KY, Niang S, Literat A, Zhu NL, Ramanathan R, Jones CA, Minoo P: Expression of transforming growth factor beta (TGF-b1) by human preterm lung inflammatory cells. Life Sci. 2006;79:2349-2356.
39. Marcho Z, White JE, Higgins PJ, Tsan MF: Tumor necrosis factor enhances endothelial cell susceptibility to oxygen toxicity: role of glutathione. Am J Respir Cell Mol Biol. 1991;5:556-562.
40. Shalaby MR, Aggarwal BB, Rinderknecht E, Svedersky LP, Finkle BS, Palladino MA Jr: Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors. J Immunol. 1985;135:2069-2073.
41. 2 toxicity: role of endogenous tumor necrosis factor. Exp Lung Res. 1995;21:589-597.
42. Choo-Wing R, Nedrelow JH, Homer RJ, Elias JA, Bhandari V: Developmental differences in the responses of IL-6 and IL-13 transgenic mice exposed to hyperoxia. Am J Physiol Lung Cell Mol Physiol. 2007;293:142-150.
43. Gauldie J, Galt T, Bonniaud P, Robbins C, Kelly M, Warburton D: Transfer of the active form of transforming growth factor-beta 1 gene to newborn rat lung induces changes consistent with bronchopulmonary dysplasia. Am J Pathol. 2003;163:2575-2584.
44. Vicencio AG, Lee CG, Cho SJ, Eickelberg O, Chuu Y, Haddad GG, Elias JA: Conditional overex-pression of bioactive transforming growth factor-beta1 in neonatal mouse lung: a new model for bronchopulmonary dysplasia? Am J Respir Cell Mol Biol. 2004;31:650-656.
45. Kunzmann S, Speer CP, Jobe AH, Kramer BW: Antenatal inflammation induced TGF-beta1 but suppressed CTGF in preterm lungs. Am J Physiol Lung Cell Mol Physiol. 2007;292:L223-L231.
46. French JF, Thomas CE, Downs TR, Ohlweiler DF, Carr AA, Dage RC: Protective effects of a cyclic nitrone antioxidant in animal models of endotoxic shock and chronic bacteremia. Circ Shock. 1994;43:130-136.
47. Sang H, Wallis GL, Stewart CA, Kotake Y: Expression of cytokines and activation of transcription factors in lipopolysaccharide-administered rats and their inhibition by phenyl N-tert-butylnitrone (PBN). Arch Biochem Biophys. 1999;363:341-348.
48. Miyajima T, Kotake Y: Spin trapping agent, phenyl N-tert-butyl nitrone, inhibits induction of nitric oxide synthase in endotoxin-induced shock in mice. Biochem Biophys Res Commun. 1995;215:114-121.
49. Lin S, Cox HJ, Rhodes PG, Cai Z: Neuroprotection of alpha-phenyl- N-tert-butyl-nitrone on the neonatal white matter is associated with anti-inflammation. Neurosci Lett. 2006;405:52-56.
50. Dubois CM, Laprise MH, Blanchette F, Gentry LE, Leduc R: Processing of transforming growth factor beta 1 precursor by human furin convertase. J Biol Chem. 1995;270:10618-10624.